GSK Price to Free Cash Flow Ratio 2010-2022 | GSK

Historical price to free cash flow ratio values for GSK (GSK) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GSK Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-09-28 29.46 4.74
2022-06-30 53.80 $6.21 8.66
2022-03-31 53.42 $6.20 8.62
2021-12-31 53.30 $4.76 11.20
2021-09-30 45.61 $4.58 9.95
2021-06-30 46.95 $3.48 13.48
2021-03-31 41.52 $4.26 9.75
2020-12-31 42.04 $4.64 9.06
2020-09-30 42.42 $4.48 9.46
2020-06-30 45.43 $5.36 8.47
2020-03-31 41.71 $4.56 9.15
2019-12-31 51.06 $4.36 11.71
2019-09-30 45.85 $4.91 9.35
2019-06-30 42.51 $4.74 8.97
2019-03-31 43.87 $4.72 9.28
2018-12-31 39.52 $4.86 8.13
2018-09-30 41.06 $3.92 10.48
2018-06-30 40.71 $3.79 10.75
2018-03-31 38.97 $3.55 10.96
2017-12-31 34.76 $3.69 9.43
2017-09-30 39.22 $2.99 13.10
2017-06-30 41.13 $2.64 15.60
2017-03-31 39.76 $2.29 17.37
2016-09-30 39.65 $2.51 15.80
2016-06-30 39.43 $1.78 22.15
2016-03-31 36.46 $-7.04 0.00
2015-12-31 35.18 $1.00 35.31
2015-09-30 33.08 $1.75 18.95
2015-06-30 35.37 $2.39 14.78
2015-03-31 38.68 $10.99 3.52
2014-12-31 35.31 $3.42 10.33
2014-09-30 37.47 $3.52 10.63
2014-06-30 43.00 $4.13 10.41
2014-03-31 42.47 $4.79 8.86
2013-12-31 41.87 $4.98 8.40
2013-09-30 38.89 $4.65 8.37
2013-06-30 38.32 $2.83 13.53
2013-03-31 35.59 $2.91 12.21
2012-12-31 32.48 $2.78 11.70
2012-09-30 34.08 $2.94 11.57
2012-06-30 33.22 $4.64 7.15
2012-03-31 32.35 $4.36 7.42
2011-12-31 32.27 $4.33 7.45
2011-09-30 28.84 $3.85 7.49
2011-06-30 29.61 $2.94 10.06
2011-03-31 26.19 $3.56 7.35
2010-12-31 26.32 $4.38 6.01
2010-09-30 26.18 $4.59 5.71
2010-06-30 22.25 $5.69 3.91
2010-03-31 24.88 $5.29 4.71
2009-12-31 26.88 $4.84 5.56
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.912B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.866B 9.33
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.885B 0.00
QIAGEN (QGEN) Netherlands $9.442B 15.81
Ginkgo Bioworks Holdings (DNA) United States $6.193B 0.00
Arcus Biosciences (RCUS) United States $1.934B 37.75
Myovant Sciences (MYOV) United Kingdom $1.735B 0.00
Emergent Biosolutions (EBS) United States $1.064B 6.16
ADC Therapeutics SA (ADCT) Switzerland $0.391B 0.00
Zymeworks (ZYME) Canada $0.323B 0.00
Enzo Biochem (ENZ) United States $0.108B 0.00
Gelesis Holdings (GLS) United States $0.082B 0.00
SQZ Biotechnologies (SQZ) United States $0.072B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00